USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
NEOSTEM, INC.
Address:
420 LEXINGTON AVE SUITE 350
NEW YORK, NY
Phone:
N/A
URL:
N/A
EIN:
122234356
DUNS:
42403451
Number of Employees:
N/A
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $851,763.00 3
SBIR Phase II $1,221,854.00 1

Award List:

Repair of boney defects by human stem cells

Award Year / Program / Phase:
2009 / SBIR / Phase I
Award Amount:
$108,746.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): In alignment with Healthy People 2010 (Arthritis/Osteoporosis) and research objectives established by the NIAMS, the overall goal of this study is to prevent illness and disability related to arthritis and osteoporosis. This study will develop a marrow… More

Repair of Bone Defects with Human Autologous Pluripotent Very Small Embryonic lik

Award Year / Program / Phase:
2012 / SBIR / Phase II
Award Amount:
$1,221,854.00
Agency:
HHS
Principal Investigator:
Denis O. Rodgerson – 510-521-7392
Abstract:
DESCRIPTION (provided by applicant): Bone loss due to fractures and disease is a serious medical condition in the US affecting millions of Americans. It is particularly a problem with oral craniofacial disorders were the costs of treating damage exceeds60 billion annually. Furthermore,… More

Development of Human, Autologous, Pluripotent Very Small Embryonic Like (VSELs) s

Award Year / Program / Phase:
2012 / SBIR / Phase I
Award Amount:
$595,252.00
Agency:
HHS
Principal Investigator:
Denis O. Rodgerson – 510-521-7392
Abstract:
DESCRIPTION (provided by applicant): In the event of a nuclear accident or terrorist bomb, large numbers of casualties will have been exposed to acute high-dose radiation. Those exposed will have compromised immune systems such that the virulence and infectivity of biological agents is… More

Development of Adult Pluripotent Very Small Embryonic Like (VSEL) Stem Cells to T

Award Year / Program / Phase:
2013 / SBIR / Phase I
Award Amount:
$147,765.00
Agency:
HHS
Principal Investigator:
Denis O. Rodgerson – 510-521-7392
Abstract:
DESCRIPTION (provided by applicant): Scleroderma is an autoimmune, connective tissue disorder which causes fibrosis of the skin and internal organs. In the skin, there is overproduction of extracellular matrix, and type 1 and 3 collagen. The disease involves vascular breakdown where the blood… More